<resource xmlns:datacite="http://datacite.org/schema/kernel-4">
<creators>
<creator>
<creatorName nameType="Personal">Rahil Noorizadeh</creatorName>
<givenName>Rahil</givenName>
<familyName>Noorizadeh</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Barbara Sax</creatorName>
<givenName>Barbara</givenName>
<familyName>Sax</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Tahereh Javaheri</creatorName>
<givenName>Tahereh</givenName>
<familyName>Javaheri</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Branka Radic-Sarikas</creatorName>
<givenName>Branka</givenName>
<familyName>Radic-Sarikas</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Valerie Fock</creatorName>
<givenName>Valerie</givenName>
<familyName>Fock</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Veveeyan Suresh</creatorName>
<givenName>Veveeyan</givenName>
<familyName>Suresh</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Maximilian Kauer</creatorName>
<givenName>Maximilian</givenName>
<familyName>Kauer</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Aleksandr Bykov</creatorName>
<givenName>Aleksandr</givenName>
<familyName>Bykov</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Danijela Kurija</creatorName>
<givenName>Danijela</givenName>
<familyName>Kurija</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Michaela Schlederer</creatorName>
<givenName>Michaela</givenName>
<familyName>Schlederer</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Lukas Kenner</creatorName>
<givenName>Lukas</givenName>
<familyName>Kenner</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Gerhard Weber</creatorName>
<givenName>Gerhard</givenName>
<familyName>Weber</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Wolfgang Mikulits</creatorName>
<givenName>Wolfgang</givenName>
<familyName>Mikulits</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Florian Halbritter</creatorName>
<givenName>Florian</givenName>
<familyName>Halbritter</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Richard Moriggl</creatorName>
<givenName>Richard</givenName>
<familyName>Moriggl</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Heinrich Kovar</creatorName>
<givenName>Heinrich</givenName>
<familyName>Kovar</familyName>
</creator>
</creators>
<titles>
<title>YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells</title>
</titles>
<publisher>Cell Press</publisher>
<publicationYear>2025</publicationYear>
<descriptions>
<description descriptionType="Other">Ewing sarcoma (EwS) is an aggressive cancer of adolescents in need of effective treatment. Insulin-like growth factor (IGF)-1 is an autocrine growth factor for EwS, but only 10% of patients respond to IGF-1 receptor (IGF-1R) blockade. Although EwS is presumed to originate from mesenchymal progenitors during bone development, targeting of the EwS driver oncogene EWS::FLI1 to the mesenchymal lineage in a mouse model does not result in tumor formation but in skeletal malformations and perinatal death. We report that transient exposure to IGF-1 concentrations mimicking serum levels during puberty reprograms limb-derived mesenchymal cells of EWS::FLI1-mutant mice to stable transformation and tumorigenicity. We identify a modular mechanism of IGF-1-driven tumor promotion in the early steps of EwS pathogenesis, in which Yap1 plays a central role. Pharmacologic Yap1/Tead inhibition reverses the transformed phenotype of EWS::FLI1-expressing cells. Our data provide a rationale for combined IGF-1R and YAP/TEAD inhibition in the treatment of EwS patients.</description>
</descriptions>
<resourceType resourceTypeGeneral="Text">PDFDocument</resourceType>
<language>eng</language>
<dates>
<date dateType="Created">2025-04-14T08:11:57.561643Z</date>
<date dateType="Issued">2025</date>
</dates>
<subjects>
<subject>Animals</subject>
<subject>Mesenchymal Stem Cells Metabolism</subject>
<subject>YAP-Signaling Proteins Metabolism</subject>
<subject>RNA-Binding Protein EWS Metabolism</subject>
<subject>RNA-Binding Protein EWS Genetics</subject>
<subject>Humans</subject>
<subject>Mice</subject>
<subject>Cell Transformation, Neoplastic Metabolism</subject>
<subject>Cell Transformation, Neoplastic Genetics</subject>
<subject>Proto-Oncogene Protein c-fli-1Metabolism</subject>
<subject>Proto-Oncogene Protein c-fli-1Genetics</subject>
<subject>Adaptor Proteins, Signal Transducing Metabolism</subject>
<subject>Insulin-Like Growth Factor I Metabolism</subject>
<subject>Transcription Factors Metabolism</subject>
<subject>Sarcoma, Ewing Metabolism</subject>
<subject>Sarcoma, Ewing Pathology</subject>
<subject>Sarcoma, Ewing Genetics</subject>
<subject>Cellular Reprogramming Drug Effects</subject>
<subject>Oncogene Proteins, Fusion Metabolism</subject>
<subject>Oncogene Proteins, Fusion Genetics</subject>
<subject>Receptor, IGF Type 1 Metabolism</subject>
<subject>Bone and Bones Metabolism</subject>
<subject>Bone and Bones Pathology</subject>
</subjects>
<sizes>
<size>5572699 b</size>
</sizes>
<formats>
<format>application/pdf</format>
</formats>
<rightsList>
<rights rightsURI="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</rights>
</rightsList>
</resource>
